Literature DB >> 1267339

Microbiology in serous otitis media.

K Lundgren, H Rundcrantz.   

Abstract

It is now established that serous otitis media (SOM) is an inflammatory reaction of the mucosa of the middle ear. A number of microbiological factors are contributory causes. It is clear, among other things, that the microbiologic environment in the nasopharynx in SOM is the same as that in acute otitis media. Neither adenoidectomy and tonsillectomy nor treatiment with conventional chemotherapeutics has proved effective for eradicating pathogenic bacteria from the nasopharynx. Intense research to find new antibiotics and effective means may be one way of getting us out of our present therapeutic dilemma. Other possibilities are to try to produce polyvalent bacterial vaccines and to increase our knowledge of the immunology of the nasopharynx.

Entities:  

Mesh:

Year:  1976        PMID: 1267339     DOI: 10.1177/00034894760850S228

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  5 in total

1.  Clinical significance of Bacteroidaceae.

Authors:  A Hudác
Journal:  Infection       Date:  1980       Impact factor: 3.553

2.  Indigenous nasopharyngeal, auditory canal, and middle ear bacterial flora of gerbils: animal model for otitis media.

Authors:  T A Thompson; D Gardner; R S Fulghum; H J Daniel; W E Allen; J M Worthington; P P Williams
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

3.  Experimental otitis media in gerbils and chinchillas with Streptococcus pneumoniae, Haemophilus influenzae, and other aerobic and anaerobic bacteria.

Authors:  R S Fulghum; J E Brinn; A M Smith; H J Daniel; P J Loesche
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

4.  The penetration of erythromycin into the middle ear.

Authors:  L Sundberg; T Edén; S Ernstson
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Beta-lactamase production in the upper respiratory tract flora.

Authors:  I Eliasson; C Kamme; K Prellner
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.